Arrowhead Pharmaceuticals
ARWR
#1768
Rank
HK$98.68 B
Marketcap
HK$698.61
Share price
0.27%
Change (1 day)
323.74%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2026 (TTM): HK$6.16

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is HK$6.35. In 2025 the company made an earnings per share (EPS) of -HK$0.07839 an increase over its 2024 EPS that were of -HK$39.20.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$6.16-7955.81%
2025-HK$0.07839-99.8%
2024-HK$39.20161.39%
2023-HK$15.0017.36%
2022-HK$12.7819.85%
2021-HK$10.6661.9%
2020-HK$6.58-216.67%
2019HK$5.64-210.77%
2018-HK$5.1038.3%
2017-HK$3.68-64.93%
2016-HK$10.50-16.25%
2015-HK$12.5428%
2014-HK$9.80-3.85%
2013-HK$10.19-31.58%
2012-HK$14.89331.82%
2011-HK$3.45-51.11%
2010-HK$7.06-79.07%
2009-HK$33.71-37.68%
2008-HK$54.09-16.87%
2007-HK$65.0638.33%
2006-HK$47.03122.22%
2005-HK$21.1742.11%
2004-HK$14.89533.33%
2003-HK$2.35-99.08%
2002-HK$254.5125%
2001-HK$203.6133.33%
2000-HK$152.71-120%
1999HK$763.54-400%
1998-HK$254.51-81.48%
1997-HK$1,374

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.47 978.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-HK$63.89-1,106.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$61.46 867.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$29.71 367.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-HK$17.79-380.25%๐Ÿ‡บ๐Ÿ‡ธ USA